Tag : chronic hepatitis B

Clinical Research, Pharma & Healthcare Financing

Ionis & GSK Report Positive Phase 3 Results for Bepirovirsen

Business Wire
by Business Wire080
– Primary endpoint met in both trials –– Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate –– Chronic hepatitis B (CHB) accounts for ~56% of...
Healthcare Quality, Patient Safety & Policy

AusperBio Completes Phase III AUSHINE Study Patient Enrollment

PR Newswire
by PR Newswire069
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic hepatitis B (CHB), today announced the completion...